ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,813Medicare Part D Prescriptions Filled, Including Refills

Rank: 68 out of 680

$906K Total Retail Price of All Prescriptions

Rank: 104 out of 680

1,146 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 1,146 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

17% of this provider’s 1,146 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 15,281 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 1,045 806 S3 1 4
ALPRAZOLAM 658 605 2 72
SIMVASTATIN 633 556 3 3
AMLODIPINE BESYLATE 493 409 4 1
LISINOPRIL 489 419 5 5
ZOLPIDEM TARTRATE 451 364 6 17
METFORMIN HCL 449 413 7 8
ATORVASTATIN CALCIUM 424 361 8 11
LEVOTHYROXINE SODIUM 410 384 9 2
TRAMADOL HCL 410 389 9 18
ATENOLOL 380 330 11 19
METOPROLOL TARTRATE 348 297 12 12
FUROSEMIDE 322 295 13 6
PANTOPRAZOLE SODIUM 303 267 14 30
OMEPRAZOLE 278 235 15 7
PREDNISONE 249 222 16 50
TRIAMTERENE-HCTZ 245 228 17 52
SERTRALINE HCL 218 206 18 28
HYDROCHLOROTHIAZIDE 204 173 19 9
DIAZEPAM 203 159 10 20 188
VIAGRA 199 158 21 214
GLYBURIDE 198 182 R 22 85
AMOXICILLIN 193 156 23 111
GABAPENTIN 191 158 24 15
DONEPEZIL HCL 183 176 25 27
LOVASTATIN 169 163 26 44
AZITHROMYCIN 162 141 27 42
TAMSULOSIN HCL 155 126 28 34
METOPROLOL SUCCINATE 137 114 29 13
PROAIR HFA 136 110 30 67
FLUTICASONE PROPIONATE 134 129 31 41
TEMAZEPAM 133 123 32 155
CLOTRIMAZOLE-BETAMETHASONE 129 120 33 138
INSULIN SYRINGE 126 105 34 86
CLOPIDOGREL 121 107 35 26
TRAZODONE HCL 117 116 36 48
LORAZEPAM 114 95 37 125
PAROXETINE HCL 106 86 38 76
CIPROFLOXACIN HCL 104 90 39 57
FINASTERIDE 101 96 40 109
FLUOXETINE HCL 100 92 41 74
POTASSIUM CHLORIDE 100 84 41 14
DETROL LA 97 96 43 169
ALLOPURINOL 96 76 44 33
CLONIDINE HCL 93 69 45 36
TRIAMCINOLONE ACETONIDE 92 74 46 199
RANITIDINE HCL 89 71 47 56
LISINOPRIL-HYDROCHLOROTHIAZIDE 89 67 47 37
PLAVIX 88 79 49 39
CARVEDILOL 86 80 50 23
PRAVASTATIN SODIUM 85 81 51 10
PREMARIN 84 66 R 52 105
ADVAIR DISKUS 82 80 53 53
LACTULOSE 81 66 54 92
ALENDRONATE SODIUM 80 80 55 32
GLIPIZIDE 80 71 55 63
LOSARTAN POTASSIUM 73 64 57 21
NAPROXEN 72 65 58 121
HYDRALAZINE HCL 71 65 59 71
NEXIUM 69 62 60 16
CELEBREX 65 62 61 90
ISOSORBIDE MONONITRATE ER 64 57 62 59
ONDANSETRON HCL 64 55 62 287
SPIRIVA 63 63 64 70
WARFARIN SODIUM 62 55 65 20
DIPHENOXYLATE-ATROPINE 61 46 66 291
ENALAPRIL MALEATE 61 55 66 65
VERAPAMIL ER 61 46 66 100
NAMENDA 59 59 69 35
GEMFIBROZIL 58 47 70 106
GLIMEPIRIDE 58 52 70 29
AMITRIPTYLINE HCL 57 53 R 72 47
OXYCODONE HCL-ACETAMINOPHEN 56 51 S2 73 133
DOXAZOSIN MESYLATE 56 56 73 73
NIFEDIPINE ER 55 51 75 75
NITROSTAT 55 49 75 295
CARISOPRODOL 55 0 R 75 83
QUETIAPINE FUMARATE 52 31 78 64
IBUPROFEN 52 26 78 126
ZOSTAVAX 52 50 78 230
OXYBUTYNIN CHLORIDE 51 47 81 129
ROPINIROLE HCL 51 47 81 99
MELOXICAM 50 41 83 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 12, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.